We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZOM
3351
DELISTED
Zomedica Corp.
ZOM
$3K ﹤0.01%
+9,773
New +$8.62K
ZN
3352
DELISTED
Zion Oil & Gas, Inc.
ZN
$3K ﹤0.01%
3,982
-3,023
-43% -$1.66K
GSB
3353
DELISTED
GlobalSCAPE, Inc.
GSB
$3K ﹤0.01%
+511
New +$2.62K
FTSI
3354
DELISTED
FTS International, Inc. Common Stock
FTSI
$3K ﹤0.01%
16
+13
+433% +$2.33K
INAP
3355
DELISTED
Internap Corporation
INAP
$3K ﹤0.01%
552
-3,086
-85% -$16.7K
ARTX
3356
DELISTED
Arotech Corporation
ARTX
$3K ﹤0.01%
1,109
+258
+30% +$824
TMCXU
3357
DELISTED
Trinity Merger Corp. Unit
TMCXU
$3K ﹤0.01%
294
PNTR
3358
DELISTED
Pointer Telocation Ltd.
PNTR
$3K ﹤0.01%
+179
New +$2.52K
CZFC
3359
DELISTED
Citizens First Corporation
CZFC
$3K ﹤0.01%
+112
New +$2.62K
EPE
3360
DELISTED
EP Energy Corporation
EPE
$3K ﹤0.01%
+13,214
New +$8.76K
ACET
3361
DELISTED
Aceto Corp
ACET
$3K ﹤0.01%
19,145
+13,364
+231% +$10.4K
CTIC
3362
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3K ﹤0.01%
2,637
-14,797
-85% -$15.6K
IHTA
3363
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$3K ﹤0.01%
+319
New +$3.07K
QIWI
3364
DELISTED
QIWI PLC
QIWI
$3K ﹤0.01%
178
-1,438
-89% -$21.1K
NHLD
3365
DELISTED
National Holdings Corporation
NHLD
$3K ﹤0.01%
+1,003
New +$3.17K
SVA
3366
DELISTED
Sinovac Biotech, Ltd
SVA
$3K ﹤0.01%
424
+89
+27% +$585
AEF
3367
abrdn Emerging Markets Equity Income Fund
AEF
$367M
$2K ﹤0.01%
297
-95
-24% -$672
AEHR icon
3368
Aehr Test Systems
AEHR
$3.36B
$2K ﹤0.01%
1,528
+942
+161% +$1.27K
AGM.A icon
3369
Federal Agricultural Mortgage Class A
AGM.A
$1.8B
$2K ﹤0.01%
+29
New +$1.97K
AHT
3370
Ashford Hospitality Trust
AHT
$21M
$2K ﹤0.01%
1
AIN icon
3371
Albany International
AIN
$1.78B
$2K ﹤0.01%
+30
New +$2.14K
AMAL icon
3372
Amalgamated Financial
AMAL
$1.49B
$2K ﹤0.01%
109
-537
-83% -$9.65K
AMKR icon
3373
Amkor Technology
AMKR
$13.7B
$2K ﹤0.01%
236
-1,164
-83% -$9.63K
APPF icon
3374
AppFolio
APPF
$7.04B
$2K ﹤0.01%
+25
New +$1.67K
ARGX icon
3375
argenx
ARGX
$54.1B
$2K ﹤0.01%
+17
New +$2K

Similar funds

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.